Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 15, 2007 (Vol. 27, No. 12)

Nanotechnology and Nanoscience

  • Good coverage of nanotechnology
  • Nothing significant
Are you getting a little tired of the ‘nano’ prefix? If you are, you may want to stay away from the Nanontechnology and Nanoscience site, which prominently features on its opening page, four sections entitled NanoBase (a material database), NanoLink (a collection of nanotech links), NanoRisk (a nanoprofessional’s newsletter), and NanoBlog (a daily nanotechnology feature article). Worse, the front page is subtitled, “NanoWerk.” Okay, you were warned. Diving into the content, one discovers that nanotechnology is worthy of the attention it gets. As one article on the opening page points out, carbon nanotubes provide hope of extending Moore’s law of computing for at least a few more years and that nanotechnology is essential for integrating biochemical analyses onto the lab-on-a-chip devices. I must object, though, to the use of the term ‘nanoverse’ to refer to the universe of nanotechnology. Is no suffix sacred when it comes to use of the nano prefix?
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »